Cardiovascular risk factors in type 2 diabetic Nigerians with clinical diabetic nephrophathy

Cardiovascular Journal of South Africa

Volumn 15, Issue 3, 2004, Pages 124-128

  Alebiosu, C O ^a   Odusan, O ^a   Familoni, O B ^a   Jaiyesimi, A E A ^a  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PROTEINURIA; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; SYSTOLIC BLOOD PRESSURE;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NIGERIA; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; WAIST-HIP RATIO;

EID: 4043118957     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. IDF Task Force on Diabetes Health Economics. Diabetes health economics: facts, figures and forecasts. International Diabetes Federation, 1999.
2. Eberhard R, Reinhold SO. Nephropathy in patients with type 2 diabetes mellitus. NEJM 1999; 342(15): 1127-1133.
3. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002; 156: 714-719.
4. Krolewski AS, Czyzyk A, Janneczko D, Kopczynski J. Mortality from cardiovascular diseases among diabetics. Diabetologia 1977; 13: 345-350.
5. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 1997; 20: 935-942.
6. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W. Frequency, risk profile and mortality of a random sample of albuminuric type 2 diabetic patients. A 5-year prospective study in general practice. Diab Stoffw 1993; 2: 62-67.
7. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy - an update. Hypertension 1995; 26: 869-879.
8. National Expert Committee on Non-Communicable disease (NCD). NCD in Nigeria. Report of National survey 1997; 64-90.
9. Osuntokun BO, Akinkugbe FM, Reddys FTI, Osuntokun O, Taylor GOL. Diabetes mellitus in Nigerians: a study of 832 patients. W Afr Med J 1971; 20: 295-312.
10. Alebiosu CO. Clinical diabetic nephropathy in a tropical african population. W Afr Med J 2003; 22: 152-155.
11. Akinsola W, Odesanmi WO, Ogunniyi JO, Ladipo GOA. Diseases causing chronic renal failure in Nigerians - a prospective study of 100 cases. Afr J Med Sci 1989; 18: 131-135.
12. Adeniyi A, Folsom AR, Brancati FL, Desvarieux M, Pankow JS, Taylor H. Incidence and risk factors for cardiovascular disease in African Americans with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. J Natl Med Assoc 2002; 94: 1025-1035.
13. Getz GS. Report on the workshop on diabetes and mechanisms of atherogenesis. September 17 and 18, 1992, Bethseda MD. Arteroscler Thromb 1993; 13: 459-464.
14. Adams-Campbell LL, Nwankwo MU, Omene JA, et al. Assessment of cardiovascular risk factors in Nigerian students. Arterioslerosis 1988; 8: 793-796.
15. Kadiri S, Salako BL. Cardiovascular risk factors in middle aged Nigerians. E Afr Med J 1997; 74(5): 33-37.
16. Jones J, Dais KA. Risk factors for coronary heart disease in a Black population. J Natl Med Assoc 1992; 84: 393-398.
17. Gæde P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N EJM 2003; 348: 383-393.
18. Araoye MA. Left ventricular hypertrophy by electrocardiogram: A code system applicable to Negroes. Nig Postgrad Med J 1996; 3: 92-97.
19. Katibi IA, Adenle AD. Comparison between various criteria for the diagnosis of left ventricular hypertrophy and electrocardiogram in adult hypertensive Nigerians. Nig Med Pract 2003; 43: 3-6.
20. Rosamond WD, Folsom AR, Chambless LE, et al. Stroke incidence and survival among middle aged adults: nine year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999; 30: 736-743.
21. Ezenwaka CE, Adejuwon CA, Akanji AO. The prevalence of cardiovascular risk factors in rural elderly Nigerians. Nig Med J 1997; 33: 62-67.
22. Lawoyin TO, Asuzu MC, Kaufman J, Rotimi C, Owoaje E, Johson L, Cooper R. Prevalence of cardiovascular risk factors in an African, urban inner city community. W Afr Med J 2002; 21(3): 208-211.
23. Akinkugbe OO. Current epidemiology of hypertension in Nigeria. Arch Ibadan Med 1999; 1: 3-5.
24. Familoni OB, Alebiosu CO, Odusan B, Raimi TH. Factors influencing target organ damage among hypertensive patients in Nigeria. Cadiovasc J South Afr 2004; 15(1): 9-12.
25. Wokoma FS. Diabetes and hypertension in Africa - an overview. Diab Int 2002; 12(2): 36-40.
26. Padwal R, Straus SE, McAllister FA. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ 2001; 322: 977-980.
27. Reaven GM. Role of insulin resistance in human disease. Banting Lecture. Diabetes 1998; 37: 1595-1607.
28. Miller ER, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ. Results of the Diet, Exercise, and Weight Loss Intervention Trial. Hypertension 2002; 40: 612-618.
29. Alebiosu CO. An update on 'progression promoters' in renal diseases. J Natl Med Assoc 2003; 95: 30-42.